CAS 84869-30-7

21-Amino-17-hydroxyprogesterone hydrochloride

Description:

21-Amino-17-hydroxyprogesterone hydrochloride is a synthetic derivative of progesterone, characterized by the presence of an amino group at the 21 position and a hydroxyl group at the 17 position of the steroid structure. This compound is typically used in pharmaceutical applications, particularly in the field of hormone replacement therapy and in the treatment of certain medical conditions related to hormonal imbalances. It exhibits properties similar to those of natural progesterone, influencing various physiological processes such as the menstrual cycle and pregnancy. The hydrochloride salt form enhances its solubility in water, facilitating its use in injectable formulations. As with many steroid derivatives, it may have a range of biological activities, including anti-inflammatory effects. Safety and efficacy profiles are determined through clinical studies, and like other hormonal treatments, it may have side effects and contraindications that need to be considered. Proper handling and storage conditions are essential to maintain its stability and effectiveness.

Formula: C₂₁H₃₂ClNO₃

InChI: InChI=1/C21H31NO3.ClH/c1-19-8-5-14(23)11-13(19)3-4-15-16(19)6-9-20(2)17(15)7-10-21(20,25)18(24)12-22;/h11,15-17,25H,3-10,12,22H2,1-2H3;1H/t15-,16+,17+,19+,20+,21+;/m1./s1

Synonyms:

• 21-Amino-17-hydroxy-4-pregnene-3,20-dione hydrochloride
• 21-Amino-17-Hydroxypregn-4-Ene-3,20-Dione Hydrochloride (1:1)

21-Amino-17-hydroxyprogesteroneHydrochloride

Controlled Product

CAS: 84869-30-7

21-Amino-17-hydroxyprogesteroneHydrochloride is a synthetic corticosteroid that is used to suppress the immune system in patients with severe allergies and those who have had an organ transplant. It binds to receptors on the surface of lymphocytes, preventing them from producing antibodies. It also inhibits the production of white blood cells by interfering with DNA synthesis and protein synthesis. 21-Amino-17-hydroxyprogesteroneHydrochloride is used to treat conditions such as sepsis, rheumatoid arthritis, lupus erythematosus, and myasthenia gravis. The medication is administered by injection into muscle or vein.

Formula: C₂₁H₃₂ClNO₃

Purity: Min. 95%

Molecular weight: 381.94 g/mol

Ref: 3D-FA150830